Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 27 February

Grady Wulff
February 27, 2023

Weekly Wrap 24 February

Grady Wulff
February 24, 2023

Morning Bell 24 February

Sophia Mavridis
February 24, 2023

Morning Bell 23 February

Grady Wulff
February 23, 2023

Morning Bell 22 February

Grady Wulff
February 22, 2023

Morning Bell 21 February

Sophia Mavridis
February 21, 2023

Morning Bell 20 February

Grady Wulff
February 20, 2023

Weekly Wrap 17 February

Grady Wulff
February 17, 2023

Morning Bell 17 February

Grady Wulff
February 17, 2023

Morning Bell 16 February

Sophia Mavridis
February 16, 2023